A diagnostic service utilizing independently developed CTC (circulating tumor cells) and ctDNA (circulating tumor DNA) detection platforms with high sensitivity and specificity. Compared to traditional detection methods, it can identify more disease information to achieve individualized precision th...
Manufactured by
China
NOROVA specializes in personalized precision medicine for malignant tumors, serving as a biomedical innovation and life sciences R&D center in the Beijing-Tianjin region. The company operates a proprietary tumor organoid precision diagnosis platform integrating drug sensitivity testing, high-throughput drug screening, and genetic testing. NOROVA also develops tumor microenvironment organ-on-chip and multi-organ chip technologies for drug development applications.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
guangzhou biotron technolongy co.,ltd
China · 5 relevant products
Biopsense Oy
Finland · 4 relevant products
GENETRON HEALTH (BEIJING) CO., LTD
China · 2 relevant products
Shanghai Biotecan pharmaceuticals Co.,Ltd
China · 3 relevant products
Dxome Co., Ltd.
South Korea · 1 relevant product
Wuhan YZY Medical Science and Technology Co.,Ltd.
China · 4 relevant products
Nonacus
United Kingdom · 3 relevant products
Singlera GENOMICS (SHANGHAI) Ltd.
China · 2 relevant products
Aliko Scientific SA
France · 4 relevant products
HLB PANAGENE Co., Ltd.
South Korea · 1 relevant product
33 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 75 closest product alternatives
guangzhou biotron technolongy co.,ltd · China
Molecular diagnostic system tracking circulating tumor cell dynamics and nucleic acid markers to evaluate cancer treatment efficacy and guide therapeutic decisions.
Biopsense Oy · Finland
Blood-based diagnostic test for monitoring cancer treatment efficacy and detecting emerging drug resistance through analysis of circulating tumor DNA. Enables rapid treatment adjustment decisions based on genetic mutation detection in cfDNA.
GENETRON HEALTH (BEIJING) CO., LTD · China
Molecular diagnostic test utilizing circulating tumor DNA and biomarkers from blood samples. Enables non-invasive cancer screening and early detection. Supports monitoring of treatment response and recurrence in cancer patients.
Biopsense Oy · Finland
Liquid biopsy diagnostic solution for non-invasive cancer monitoring and treatment personalization through cell-free DNA analysis. Automates plasma separation, DNA extraction, and quantitation to reduce pre-analytical variability and enable frequent patient monitoring for improved treatment response assessment.
Shanghai Biotecan pharmaceuticals Co.,Ltd · China
Molecular diagnostic test for monitoring therapeutic response and detecting minimal residual disease in cancer patients. Supports ongoing treatment optimization and prognosis assessment.
guangzhou biotron technolongy co.,ltd · China
A next-generation circulating tumor cell detection system based on microfluidic chips and AI interpretation that captures cancer cells from a single blood sample. It enables non-invasive tumor monitoring, assists in lung nodule diagnosis, perioperative guidance, and treatment monitoring for precision oncology.
Dxome Co., Ltd. · South Korea
A cutting-edge liquid biopsy product that analyzes circulating tumor DNA (ctDNA) to identify somatic mutations. It aids in treatment selection, response monitoring, and recurrence detection for optimal cancer care.
Wuhan YZY Medical Science and Technology Co.,Ltd. · China
Circulating Tumor Cell (CTC) detection products that identify and analyze tumor cells in patient blood samples. These products provide critical diagnostic information for cancer monitoring and treatment planning.
Nonacus · United Kingdom
Comprehensive sequencing panels for cancer detection and monitoring combining tissue and liquid biopsy approaches. Enables precise identification of low-frequency variants and supports informed treatment decision-making in oncology clinical practice and research.
Singlera GENOMICS (SHANGHAI) Ltd. · China
A liquid biopsy-based test utilizing DNA methylation markers for post-treatment cancer recurrence monitoring and surveillance. Enables early detection of disease relapse and progression.
Aliko Scientific SA · France
Comprehensive diagnostic solutions for cancer detection and treatment monitoring utilizing FISH and circulating tumor cell (CTC) detection technology. These solutions enable personalized medicine approaches and targeted therapy delivery.
Biopsense Oy · Finland
Cell-free DNA (cfDNA) liquid biopsy test for non-invasive cancer diagnosis and treatment monitoring. Analyzes circulating tumor DNA in blood to detect cancer-causing mutations and guide personalized oncology treatment decisions. Reduces need for invasive tissue sampling and enables frequent monitoring for treatment response assessment.
63 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products